There are 2137 resources available
12P - Genome mining-aided biosynthesis overcomes Temozolomide-resistant glioblastoma via negatively regulating cIAP-mediated degradation of PACS2 and ER-mitochondria contact sites
Presenter: Lei Chen
Session: E-Poster Display
Resources:
Abstract
13P - Synergistic activity of PARP inhibitor and ATR inhibitor in melanoma cell lines may depend on BRAF-V600 mutation status
Presenter: Emilio Giunta
Session: E-Poster Display
Resources:
Abstract
10P - Targeting Angiomotin-p130 reverse resistance to antiangiogenic therapies in breast cancer by inhibition of vasculogenic mimicry
Presenter: Yanwei Shen
Session: E-Poster Display
Resources:
Abstract
11P - Preclinical evaluation of DS-2087b, a novel and selective inhibitor of EGFR/HER2 exon 20 insertions
Presenter: Yasuhito Nagamoto
Session: E-Poster Display
Resources:
Abstract
14P - Modulation of MCF-7 cell sensitivity to anticancer agents by targeting glycolysis
Presenter: Alexander Scherbakov
Session: E-Poster Display
Resources:
Abstract
15P - Study on the mechanism of apatinib reversing tamoxifen resistance in breast cancer
Presenter: Qingxia Li
Session: E-Poster Display
Resources:
Abstract
16P - Development of novel combination of Imatinib and Thymoquinone on colon cancer cell line
Presenter: Mervat Omran
Session: E-Poster Display
Resources:
Abstract
17P - Engineering and expression of constitutive activators of the PD-1 and LAG-3 signaling pathways
Presenter: Luisa Chocarro
Session: E-Poster Display
Resources:
Abstract
18P - Prolonged in-use stability of reconstituted atezolizumab in commercial intravenous bags
Presenter: Ada Hui
Session: E-Poster Display
Resources:
Abstract
19P - Deep eutectic solvent mixture formed from 2-deoxy-D-glucose and metformin targets cancer cell metabolism and induces apoptosis in breast cancer cell line xenografts
Presenter: Kai Reinikainen
Session: E-Poster Display
Resources:
Abstract